Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Description Melanotan 2 (MT-2) Research Peptide (10 mg) Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of endogenous -melanocyte-stimulating hormone (-MSH), developed at the University of Arizona as a structurally minimized, conformationally constrained derivative designed to improve metabolic stability and receptor selectivity relative to the native hormone and its linear analogue Melanotan 1
Retatrutide (LY3437943), developed by Eli Lilly, is a once-weekly injectable GIP/GLP-1/glucagon triple receptor agonist
Given the recognized window of opportunity in early PsA, future research should prioritize trials in patients with subclinical joint involvement, arthralgia, or early enthesitis, especially those with coexisting obesity or MetS
US$ 24.68
US$ 26.34
US$ 22.06
US$ 26.14
US$ 22.96
US$ 28.81
US$ 20.23
US$ 26.97
